Covalon Technologies Ltd. (TSXV:COV)
Canada
· Delayed Price · Currency is CAD 1.820
-0.040 (-2.15%)
Mar 9, 2026, 3:18 PM EST
Covalon Technologies Revenue
Covalon Technologies had revenue of 6.89M CAD in the quarter ending December 31, 2025, a decrease of -15.65%. This brings the company's revenue in the last twelve months to 31.54M, down -9.04% year-over-year. In the fiscal year ending September 30, 2025, Covalon Technologies had annual revenue of 32.82M with 5.29% growth.
Revenue (ttm)
31.54M
Revenue Growth
-9.04%
P/S Ratio
1.59
Revenue / Employee
852.40K
Employees
37
Market Cap
50.26M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 32.82M | 1.65M | 5.29% |
| Sep 30, 2024 | 31.17M | 4.57M | 17.20% |
| Sep 30, 2023 | 26.60M | 8.45M | 46.56% |
| Sep 30, 2022 | 18.15M | -1.41M | -7.23% |
| Sep 30, 2021 | 19.56M | 6.05M | 44.81% |
| Sep 30, 2020 | Pro | Pro | Pro |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.74B |
| Extendicare | 1.66B |
| Sienna Senior Living | 1.00B |
| Green Thumb Industries | 1.61B |
| Leef Brands | 45.21M |
| C21 Investments | 45.62M |
| LSL Pharma Group | 26.80M |
| ZYUS Life Sciences | 465.00K |
Covalon Technologies News
- 12 days ago - Covalon Technologies Ltd (CVALF) Q1 2026 Earnings Call Highlights: Navigating Revenue ... - GuruFocus
- 12 days ago - Q1 2026 Covalon Technologies Ltd Earnings Call Transcript - GuruFocus
- 12 days ago - Covalon Technologies Ltd Q1 Earnings Summary - Nasdaq
- 12 days ago - Covalon Reports on 2026 First Quarter Results and Recent Achievements and Highlights - Business Wire
- 18 days ago - Covalon Honoured to Partner with the Association for Vascular Access and Global Expert Dr. Nancy Moureau to Tackle Critical IV Therapy Complications - Business Wire
- 18 days ago - Covalon Announces Conference Call to Discuss First Quarter Fiscal 2026 Results - Business Wire
- 3 months ago - Covalon Technologies Ltd (CVALF) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... - GuruFocus
- 3 months ago - Q4 2025 Covalon Technologies Ltd Earnings Call Transcript - GuruFocus